Finally, and in the same vein, loss of SNORD115 might only become apparent under perturbed metabolic contexts, perhaps as ‘secondary disease-effects’ once obesity is fully established in individuals with PWS. This evidence concerns the gene SNORD115 and obesity due to melanocortin 4 receptor deficiency.